Literature DB >> 3120188

Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone.

N Ueno1, N Ling, S Y Ying, F Esch, S Shimasaki, R Guillemin.   

Abstract

A Mr 35,000 protein with follicle-stimulating hormone release-inhibitory activity was isolated from porcine ovarian follicular fluid by heparin-Sepharose affinity chromatography, gel filtration on Sephacryl S-200, and multiple steps of high-performance liquid chromatography. The isolated molecule is highly enriched in cysteines and is composed of a single polypeptide chain. In addition, it has no sequence homology with the previously characterized follicular fluid inhibins, which are heterodimeric proteins of Mr 32,000 with follicle-stimulating hormone release-inhibiting activity. This protein specifically inhibits the basal secretion of follicle-stimulating hormone, but not that of luteinizing hormone, in the rat anterior pituitary monolayer culture system with a half-maximal effective dose of 2.5-6.0 ng/ml. Another form of the molecule of Mr 32,000 present in much lower concentration in follicular fluid was also isolated. It may differ from the Mr 35,000 form in glycosylation or carboxyl-terminal truncation. We suggest that this compound be called "follistatin" to signify its structural difference from inhibin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120188      PMCID: PMC299526          DOI: 10.1073/pnas.84.23.8282

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  Inhibin: from concept to reality.

Authors:  P Franchimont; J Verstraelen-Proyard; M T Hazee-Hagelstein; C Renard; A Demoulin; J P Bourguignon; J Hustin
Journal:  Vitam Horm       Date:  1979       Impact factor: 3.421

2.  Isolation of a 31 kDa form of inhibin from bovine follicular fluid.

Authors:  D M Robertson; F L de Vos; L M Foulds; R I McLachlan; H G Burger; F J Morgan; M T Hearn; D M de Kretser
Journal:  Mol Cell Endocrinol       Date:  1986-03       Impact factor: 4.102

3.  Isolation of bovine follicular fluid inhibin of about 32 kDa.

Authors:  M Fukuda; K Miyamoto; Y Hasegawa; M Nomura; M Igarashi; K Kangawa; H Matsuo
Journal:  Mol Cell Endocrinol       Date:  1986-01       Impact factor: 4.102

4.  Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin.

Authors:  N Ling; S Y Ying; N Ueno; S Shimasaki; F Esch; M Hotta; R Guillemin
Journal:  Nature       Date:  1986 Jun 19-25       Impact factor: 49.962

5.  A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone.

Authors:  N Ling; S Y Ying; N Ueno; S Shimasaki; F Esch; M Hotta; R Guillemin
Journal:  Biochem Biophys Res Commun       Date:  1986-08-14       Impact factor: 3.575

6.  Demonstration of high molecular weight forms of inhibin in bovine follicular fluid (bFF) by using monoclonal antibodies to bFF 32K inhibin.

Authors:  K Miyamoto; Y Hasegawa; M Fukuda; M Igarashi
Journal:  Biochem Biophys Res Commun       Date:  1986-05-14       Impact factor: 3.575

7.  High-sensitivity amino acid analysis: methodology for the determination of amino acid compositions with less than 100 picomoles of peptides.

Authors:  P Böhlen; R Schroeder
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

8.  Pituitary immunoreactive gamma-melanotropins are glycosylated oligopeptides.

Authors:  T Shibasaki; N Ling; R Guillemin
Journal:  Nature       Date:  1980-06-05       Impact factor: 49.962

9.  Isolation of porcine follicular fluid inhibin of 32K daltons.

Authors:  K Miyamoto; Y Hasegawa; M Fukuda; M Nomura; M Igarashi; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1985-06-14       Impact factor: 3.575

10.  Polypeptide microsequence analysis with the commercially available gas-phase sequencer.

Authors:  F S Esch
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

View more
  54 in total

Review 1.  Recent advances in the human physiology of inhibin secretion.

Authors:  D M de Kretser; D M Robertson; G P Risbridger
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

2.  Overexpression of follistatin in the mouse epididymis disrupts fluid resorption and sperm transit in testicular excurrent ducts.

Authors:  Darcie D Seachrist; Emhonta Johnson; Christianne Magee; Colin M Clay; James K Graham; D N Rao Veeramachaneni; Ruth A Keri
Journal:  Biol Reprod       Date:  2012-08-23       Impact factor: 4.285

3.  Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.

Authors:  Jennifer N Cash; Elizabeth B Angerman; Henry T Keutmann; Thomas B Thompson
Journal:  Mol Endocrinol       Date:  2012-05-16

4.  Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma.

Authors:  Christopher W Seder; Wibisono Hartojo; Lin Lin; Amy L Silvers; Zhuwen Wang; Dafydd G Thomas; Thomas J Giordano; Guoan Chen; Andrew C Chang; Mark B Orringer; David G Beer
Journal:  Neoplasia       Date:  2009-04       Impact factor: 5.715

5.  Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.

Authors:  Nevine El-Abd; Amal Fawzy; Tamer Elbaz; Sherif Hamdy
Journal:  Tumour Biol       Date:  2015-07-20

Review 6.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 7.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

8.  Structure of myostatin·follistatin-like 3: N-terminal domains of follistatin-type molecules exhibit alternate modes of binding.

Authors:  Jennifer N Cash; Elizabeth B Angerman; Chandramohan Kattamuri; Kristof Nolan; Huaying Zhao; Yisrael Sidis; Henry T Keutmann; Thomas B Thompson
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

9.  Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival.

Authors:  Tetsu Miyamoto; Juan Jesús Carrero; Abdul Rashid Qureshi; Björn Anderstam; Olof Heimbürger; Peter Bárány; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin J Am Soc Nephrol       Date:  2011-02-24       Impact factor: 8.237

10.  Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif.

Authors:  Chandramohan Kattamuri; Kristof Nolan; Thomas B Thompson
Journal:  Biochem J       Date:  2017-03-08       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.